You are viewing an incomplete version of our website. Please click to reload the website as full version.

Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2) ELISA Kits

The precise function of PARK2 is unknown\; however, the encoded protein is a component of a multiprotein E3 ubiquitin ligase complex that mediates the targeting of substrate proteins for proteasomal degradation. Additionally we are shipping PARK2 Antibodies (204) and PARK2 Proteins (8) and many more products for this protein.

list all ELISA KIts Gene Name GeneID UniProt
PARK2 50873 Q9WVS6
PARK2 56816 Q9JK66
PARK2 5071 O60260
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top PARK2 ELISA Kits at antibodies-online.com

Showing 10 out of 23 products:

Catalog No. Reactivity Sensitivity Range Quantity Supplier Delivery Price Details
Human 0.053 ng/mL 0.15-10 ng/mL 96 Tests Log in to see 9 to 11 Days
$810.53
Details
Mouse 0.78 pg/ml 3.12-200 pg/mL 96 Tests Log in to see 11 to 13 Days
$910.56
Details
Rat
96 Tests Log in to see 11 to 13 Days
$832.86
Details
Human
96 Tests Log in to see 11 to 13 Days
$832.86
Details
Mouse
96 Tests Log in to see 11 to 13 Days
$832.86
Details
Rabbit
96 Tests Log in to see 11 to 13 Days
$832.86
Details
Guinea Pig
96 Tests Log in to see 11 to 13 Days
$832.86
Details
Pig
96 Tests Log in to see 11 to 13 Days
$864.29
Details
Goat
96 Tests Log in to see 11 to 13 Days
$864.29
Details
Cow
96 Tests Log in to see 11 to 13 Days
$864.29
Details

More ELISA Kits for PARK2 Interaction Partners

Fruit Fly (Drosophila melanogaster) Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2) interaction partners

  1. We demonstrate here that vps35 (show vps35 ELISA Kits) genetically interacts with parkin

  2. Clu directly modulates mitochondrial function, and that Clu's function contributes to the PINK1-Park pathway of mitochondrial quality control.

  3. Human Mask homolog ANKHD1 (show ANKHD1 ELISA Kits) may serve as a potential therapeutic target for treating Parkinson disease caused by pink1/parkin mutations.

  4. These results indicate that the in vivo rescue is due to restoring CI activity rather than promoting mitophagy Our findings support the emerging view that PINK1 plays a role in regulating CI activity separate from its role with Parkin in mitophagy

  5. MUL1 acts in parallel to the PINK1/parkin pathway on a shared target mitofusin (show MFN2 ELISA Kits) to maintain mitochondrial integrity.

  6. Parkin cooperates with PINK1 to promote hnRNP-F/Glo ubiquitination and nRCC mRNA translation.

  7. The loss-of-function mutation in parkin results in defective immune response against bacterial infection. Additionally, parkin mutant larvae showed hypersensitivity against wound regardless of bacterial infection.

  8. data thus support the potential of folic acid in alleviating the behavioural defects, oxidative stress, augmentation of zinc and ATP levels in parkin knock down flies

  9. Parkin phosphorylation by PINK1 drives Parkin E3 activity. endogenous PINK1 precisely controls Parkin activity to maintain the mitochondrial function in muscle tissue and the neuronal function in dopaminergic neurons.

  10. Our findings thus suggest that Lon plays an essential role in regulating the PINK1-Parkin pathway by promoting the degradation of PINK1 in the matrix of healthy mitochondria

Mouse (Murine) Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2) interaction partners

  1. p62 (show GTF2H1 ELISA Kits) are subjected to parkin mediated proteasomal degradation

  2. A comprehensive analysis of influence of the Parkinson disease-associated genes Parkin and DJ-1 (show PARK7 ELISA Kits) on neurotransmitter receptor (show GRIN1 ELISA Kits) expression in mice

  3. Whereas Parkin has been reported to positively regulate the expression of OPA1 (show MED12 ELISA Kits) through NEMO (show IKBKG ELISA Kits), herein we found that PARK2 overexpression did not modify the expression of OPA1 (show MED12 ELISA Kits).

  4. In mouse hearts Parkin functions as a stress-induced and developmentally-programmed facilitator of cardiomyocyte mitochondrial turnover. (Review)

  5. findings support the notion that BAG2 (show BAG2 ELISA Kits) is an upstream regulator of the PINK1/PARKIN signaling pathway.

  6. The PINK1-Parkin pathway is activated in response to metabolic stress

  7. Overexpressed human wild type alpha-synuclein (show SNCA ELISA Kits) in the substantia nigra was phosphorylated at Ser (show SIGLEC1 ELISA Kits) 129 significantly more in parkin knockout mice, though the total alpha synuclein (show SNCA ELISA Kits) levels were the same as in wild type mice.

  8. analysis of two types of mitophagy, a DNM1L (show DNM1L ELISA Kits)-dependent pathway and a PARK2-dependent pathway

  9. FBXW8 (show FBXW8 ELISA Kits) and PARK2 are sequestrated into insolubility by ATXN2 (show ATXN2 ELISA Kits) PolyQ expansions, but only FBXW8 (show FBXW8 ELISA Kits) expression is dysregulated

  10. PARK2 function where damaged mitochondria are targeted for degradation via a PARK2/PINK1-mediated mechanism.

Human Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2) interaction partners

  1. Fibroblasts isolated from skin biopsy specimens from patients with genetic forms of Parkinson's disease, carriers of mutations in LRRK2 (show LRRK2 ELISA Kits) and PARK2 genes, and from a healthy volunteer were reprogrammed into induced pluripotent stem cells.

  2. PARK2 mutant neuroprogenitors show increased cytotoxicity with copper (Cu) and cadmium (Cd) exposure, and a substantial increase in mitochondrial fragmentation, initial ROS (show ROS1 ELISA Kits) generation, and loss of mitochondrial membrane potential following Cu exposure.

  3. These studies provide valuable insight into the roles, and cellular hierarchy, of distinct phosphorylation events in parkin activation, and profiles mutations in Parkinson's patients.

  4. UBL domain specifically interacts with the R1 domain and negatively regulates Parkin E3 ligase activity.

  5. A recent report, solving the structure of a Parkin-phosphoubiquitin complex, greatly advances the understanding of the Parkin activation mechanism.

  6. Study shows that heterozygous carriers of copy number variants affecting exons of PARK2 have greater risk of Parkinson's disease than non-carriers.

  7. A role was established for Parkin in regulating the endo-lysomal pathway.

  8. pathogenic PINK1 mutants which are not cleaved by PARL (show PARL ELISA Kits) affect PINK1 kinase activity and the ability to induce PARK2-mediated mitophagy.

  9. Maintenance of appropriate mitochondrial HSD17B10 (show HSD17B10 ELISA Kits) levels is one of mechanisms by which PARK2 preserves mitochondrial quality. The loss of this protective mechanism may contribute to mitochondrial dysfunction and neuronal degeneration in Parkinson Disease

  10. Epistatic SNP-SNP interactions involving PARK2 and cytokine genes provide an additive risk towards leprosy susceptibility.

Pig (Porcine) Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2) interaction partners

  1. Single nucleotide polymorphism (SNP) analysis revealed seven SNPs in the porcine PARK2 gene, one missense and one silent mutation in exon 7 and five SNPs in intron 7

PARK2 Antigen Profile

Antigen Summary

The precise function of this gene is unknown\; however, the encoded protein is a component of a multiprotein E3 ubiquitin ligase complex that mediates the targeting of substrate proteins for proteasomal degradation. Mutations in this gene are known to cause Parkinson disease and autosomal recessive juvenile Parkinson disease. Alternative splicing of this gene produces multiple transcript variants encoding distinct isoforms. Additional splice variants of this gene have been described but currently lack transcript support.

Gene names and symbols associated with PARK2

  • parkin (park) antibody
  • Parkinson disease (autosomal recessive, juvenile) 2, parkin (park2) antibody
  • parkinson protein 2, E3 ubiquitin protein ligase (parkin) (PARK2) antibody
  • parkin (CpipJ_CPIJ014867) antibody
  • Parkinson disease (autosomal recessive, juvenile) 2, parkin (LOC100150461) antibody
  • Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) antibody
  • parkinson protein 2, E3 ubiquitin protein ligase (Park2) antibody
  • parkinson protein 2, E3 ubiquitin protein ligase (parkin) (Park2) antibody
  • AR-JP antibody
  • CG10523 antibody
  • Dmel\\CG10523 antibody
  • Dpark antibody
  • dpk antibody
  • LOC100150461 antibody
  • LPRS2 antibody
  • Park antibody
  • PDJ antibody
  • pdr-1 antibody
  • Prkn antibody
  • SD01679 antibody
  • si:ch211-123f21.1 antibody
  • zgc:112390 antibody

Protein level used designations for PARK2

CG10523-PB , CG10523-PC , D-parkin , dparkin , park-PB , park-PC , E3 ubiquitin-protein ligase parkin , parkin , Parkinson disease (autosomal recessive, juvenile) 2, parkin , parkin protein , parkin variant SV5DEL , parkinson juvenile disease protein 2

GENE ID SPECIES
40336 Drosophila melanogaster
550328 Danio rerio
741350 Pan troglodytes
6049109 Culex quinquefasciatus
100150461 Danio rerio
50873 Mus musculus
56816 Rattus norvegicus
5071 Homo sapiens
612316 Canis lupus familiaris
733673 Sus scrofa
100724550 Cavia porcellus
Selected quality suppliers for PARK2 (PARK2) ELISA Kits
Did you look for something else?